CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-04-07 | Bernard Gordon R Director | Grant or award | +1,000 | $6.45 | $6K | 117,729 |
| 2017-04-07 | Lawrence Thomas R Director | Sale | −6,000 | $6.40 | $38K | 0 |
| 2017-04-07 | Cearnal Martin E Sr VP/Chief Commercial Officer | Grant or award | +11,600 | $6.45 | $75K | 142,516 |
| 2017-04-07 | Cearnal Martin E Sr VP/Chief Commercial Officer | Shares withheld for taxes | −1,959 | $6.45 | $13K | 140,557 |
| 2017-04-07 | Herman James L VP and Chief Compliance Office | Grant or award | +6,000 | $6.45 | $39K | 44,744 |
| 2017-04-07 | Herman James L VP and Chief Compliance Office | Shares withheld for taxes | −1,796 | $6.45 | $12K | 42,948 |
| 2017-04-07 | KAZIMI A J Chairman and CEO | Grant or award | +100,000 | $6.45 | $645K | 5,858,845 |
| 2017-04-07 | KAZIMI A J Chairman and CEO | Shares withheld for taxes | −13,575 | $6.45 | $88K | 5,845,270 |
| 2017-04-07 | Pavliv Leo SVP and Chief Development Off. | Grant or award | +10,000 | $6.45 | $65K | 111,443 |
| 2017-04-07 | Pavliv Leo SVP and Chief Development Off. | Shares withheld for taxes | −3,582 | $6.45 | $23K | 107,861 |
| 2017-04-07 | Bonner Michael Chief Financial Officer | Grant or award | +2,500 | $6.45 | $16K | 15,300 |
| 2017-04-07 | Bonner Michael Chief Financial Officer | Shares withheld for taxes | −653 | $6.45 | $4K | 14,647 |
| 2017-03-23 | Bonner Michael Chief Financial Officer | Purchase | +900 | $6.42 | $6K | 12,800 |
| 2017-03-21 | Krogulski Kenneth Director | Purchase | +15,000 | $6.53 | $98K | 150,000 |
| 2017-03-13 | Lawrence Thomas R Director | Sale | −20,781 | $6.24 | $130K | 6,000 |
| 2016-11-17 | Bonner Michael Chief Financial Officer | Purchase | +900 | $5.50 | $5K | 11,900 |
| 2016-11-15 | Lawrence Thomas R Director | Sale | −18,600 | $5.07 | $94K | 26,781 |
| 2016-08-17 | Lawrence Thomas R Director | Sale | −3,000 | $4.60 | $14K | 45,381 |
| 2016-05-26 | Herman James L VP and Chief Compliance Office | Shares withheld for taxes | −3,840 | $4.51 | $17K | 38,744 |
| 2016-05-26 | Pavliv Leo SVP and Chief Development Off. | Shares withheld for taxes | −7,296 | $4.51 | $33K | 101,443 |
Page 203 of 207 · 4,129 trades